Clinical trials
Type 1 diabetes clinical trials
An autoimmune condition where the body makes little or no insulin. We’re tracking 862 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07722910Recruiting
Iris blood flow in diabetic neovascular glaucoma
This study uses a special camera (OCTA) to look at blood flow in the iris of people with or without type 2 diabetes and diabetic neovascular glaucoma. The goal is to understand how blood flow changes in this eye condition.
Jinan, ShandongAges 18 years+ - NCT07619157RecruitingPhase 1
ONO-3310 Study for Kidney Disease and Type 2 Diabetes
This early-stage trial tests a new drug called ONO-3310 in two groups: healthy adults and people with kidney disease caused by type 2 diabetes. The study aims to understand how the drug works and whether it might help protect kidney function in people with diabetes.
Fukuoka, FukuokaAges 18–64 - NCT05570734Recruiting
Study of diabetes support for Hispanic/Latino adults online
This study looks at an online (e-health) way to help adults with type 2 diabetes better follow their diabetes care plan. It targets Hispanic/Latino patients and may help improve how consistently people manage their diabetes.
Chula Vista, CaliforniaAges 18 years+ - NCT03059069RecruitingPhase 4
Gliatamin for low mood in adults with type 2 diabetes
This trial tests whether gliatamin (choline alphoscerate) can improve depressive mood in people with type 2 diabetes. You may be eligible if your diabetes is fairly controlled and your depression symptoms are in a mild-to-moderate range.
SeoulAges 50 years+ - NCT07094529Recruiting
Tailored low blood sugar treatment for type 2 diabetes
This study tests a personalized approach to treating low blood sugar (hypoglycemia) in adults with type 2 diabetes. It aims to find out if this tailored treatment plan is practical and helpful for people who take certain diabetes medications (sulfonylureas or insulin).
Ottawa, OntarioAges 18 years+ - NCT06869057Recruiting
Improving diabetes care after hospital discharge
This study tests a redesigned discharge process to help people with type 2 diabetes manage their health after leaving the hospital. It focuses on patients who also have unmet social needs, like food or housing issues.
Worcester, MassachusettsAges 18 years+ - NCT05041491RecruitingEarly Phase 1
Breaking up sitting time to improve blood sugar
This study tests whether changing how often you sit (adding movement breaks) can improve blood sugar control in people at risk for type 2 diabetes. It compares two activity patterns and uses monitoring and brief hospital-style visits with controlled food.
Aurora, ColoradoAges 18–64 - NCT06497595Recruiting
Lifestyle program to prevent muscle loss in older adults with diabetes on semaglutide
This trial tests whether a lifestyle program (diet and exercise) can help prevent muscle loss in people 65 and older with type 2 diabetes and obesity who are taking semaglutide. It may help you keep your strength and independence while losing weight.
Jerusalem, IsraelAges 65 years+ - NCT07485075Recruiting
Digital support to cut salt intake for kidney disease
This trial tests a digital program to help people with type 2 diabetes and kidney disease reduce the salt in their diet. The goal is to see if online support can help protect the kidneys and heart.
Herlev, Captial Region of DenmarkAges 18–74 - NCT06138743Enrolling by invitationPhase 1/Phase 2
Investigational treatment for adult-onset myotonic dystrophy type 1
This trial is testing a new drug called SRP-1003 for people with myotonic dystrophy type 1 (DM1) who developed symptoms after age 12. The goal is to see if it can reduce muscle problems like myotonia (difficulty relaxing muscles) and improve daily function.
Liverpool, New South WalesAges 18–65 - NCT07309094Recruiting
Effects of a diabetes drug on fat tissue in kidney disease
This trial tests whether a GLP-1 receptor agonist (a type of diabetes medication) can improve fat tissue health in people with chronic kidney disease who also have type 2 diabetes, cardiovascular disease, or obesity. It may help protect your kidneys and overall health.
Valencia, ValenciaAges 18–90 - NCT06957093Recruiting
AI‐assisted diabetes care vs standard management
This study tests whether an AI‐powered digital health platform can help people with type 2 diabetes better manage their blood sugar. If you use a smartphone and have had diabetes for at least a year, this may be a convenient way to receive extra support.
Changchun, JilinAges 18–75 - NCT03981575Recruiting
Biomarker and health marker study in myotonic dystrophy type 1
This study measures physical and lab “health markers” in people with myotonic dystrophy type 1 (DM1) to better understand how the disease changes over time. Some participants may also have a muscle biopsy to study tissue differences.
La Jolla, CaliforniaAges 18–70 - NCT02817360RecruitingPhase 4
Preventing heart events in people with type 2 diabetes
This trial tests a heart-focused prevention approach to lower the risk of cardiac (heart) events in adults with type 2 diabetes. It may help by targeting early stress on the heart measured with a specific blood test.
Mödling, Lower AustriaAges 18 years+ - NCT06567795Recruiting
Monitoring heart risk with a wearable sensor in diabetes
This trial tests a wearable chest sensor (called HEMOTAG) to monitor heart events in people with long-standing Type 2 diabetes who also have heart disease or specific diabetes-related complications. The sensor is worn at home for short periods to catch early signs of heart trouble, aiming to improve personalized care.
West Palm Beach, FloridaAges 40 years+ - NCT07422831Enrolling by invitation
Intermittent glucose sensor use for type 2 diabetes
This trial is testing whether using a continuous glucose monitor (CGM) for different lengths of time helps people with type 2 diabetes understand their blood sugar patterns. You won't need to change your current diabetes medications.
Aurora, ColoradoAges 18 years+ - NCT05970237Recruiting
Dapagliflozin for type 2 diabetes with high blood pressure
This trial studies whether dapagliflozin (the medicine in Trudapa tabs) is safe and works in people who have both type 2 diabetes and high blood pressure. It may help control blood sugar and blood pressure, while researchers closely watch for side effects.
Incheon, Namdong-guAges 19 years+ - NCT05911256Enrolling by invitation
Community health coach plus pharmacist to improve diabetes sugars
This study tests whether a team of community health worker and pharmacist can help improve blood sugar control in people with type 2 diabetes. You may be asked to use a continuous glucose monitor (a sensor that tracks sugar levels) and take part in support visits.
Worcester, MassachusettsAges 25–75 - NCT07392437Recruiting
Study on diabetes distress in type 2 diabetes patients
This study looks at the emotional stress related to managing type 2 diabetes, known as diabetes distress. The goal is to understand how common it is and what factors may contribute to it.
NiceAges 18 years+ - NCT07506356Recruiting
Stomach emptying in diabetes patients on GLP-1 drugs
This study uses an ultrasound to check how fast your stomach empties food. It looks at people with type 2 diabetes who have been taking a GLP-1 medication for at least three months.
Geneva, Canton of GenevaAges 18 years+ - NCT07008469Enrolling by invitationPhase 3
Long-term safety study of del-desiran for DM1
This study tests whether the drug del-desiran continues to be safe and effective for people with DM1 (myotonic dystrophy type 1) after they complete an earlier study. You'll receive the drug and have regular check-ups to see how you're doing.
Los Angeles, CaliforniaAges 16 years+ - NCT05324488Recruiting
Graz diabetes registry for studying blood biomarkers
This study is a diabetes registry that collects health and blood information to learn what “biomarkers” (measurable signs in the body) can tell us about diabetes and related conditions. It may help researchers better understand diabetes and possibly improve future testing or care.
GrazAges 18–99 - NCT07270068Recruiting
Diabetes remission through lifestyle change for Malaysian patients
This study tests whether a lifestyle program can help Malaysian adults with recently diagnosed type 2 diabetes and overweight or obesity achieve remission of their diabetes. If you qualify, you’ll get support to change your diet and activity habits.
Seremban, Negeri SembilamAges 18–70 - NCT06337357Recruiting
Strength training for older adults with diabetes and muscle loss
This trial tests whether a specific strength-training program (called progressive resistance training) can help older adults with both type 2 diabetes and sarcopenia (muscle loss) improve muscle strength and overall function.
HanoiAges 60–80
Hear when a new Type 1 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for type 1 diabetes?
- Yes. Clin2 currently lists 862 recruiting type 1 diabetes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a type 1 diabetes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a type 1 diabetes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.